In this episode of #AskDrDurie, IMF Chairman Dr. Brian Durie offers his take on whether or not maintenance is recommended for a patient who has already achieved a stringent complete remission (SCR) with his or her myeloma.
Dr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.